News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Driscoll Martin J
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 11/23/2020 |
4
| Driscoll Martin J (President and CEO) has filed a Form 4 on F-star Therapeutics, Inc.|
Txns:
| Granted 15,000 shares
@ $0
Sold 175 shares
@ $4.76, valued at
$833
Exercised 10,000 restricted stock units
@ $0
Disposed of 5,475 warrants
@ $43.16, valued at
$236.3k
|
|
| 03/09/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/14/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/29/2019 |
4
| Driscoll Martin J (President and CEO) has filed a Form 4 on Spring Bank Pharmaceuticals, Inc.|
Txns:
| Bought 10,000 shares
@ $6.03, valued at
$60.3k
|
|
| 05/22/2019 |
4
| Driscoll Martin J (President and CEO) has filed a Form 4 on Spring Bank Pharmaceuticals, Inc.|
Txns:
| Bought 5,000 shares
@ $6.63, valued at
$33.2k
|
|
| 04/30/2019 |
4
| Driscoll Martin J (President and CEO) has filed a Form 4 on Spring Bank Pharmaceuticals, Inc.|
Txns:
| Bought 5,000 shares
@ $7.31, valued at
$36.6k
Bought 5,000 shares
@ $7.36, valued at
$36.8k
|
|
| 01/25/2019 |
4
| Driscoll Martin J (President and CEO) has filed a Form 4 on Spring Bank Pharmaceuticals, Inc.|
Txns:
| Granted 50,000 options to buy
@ $10.35, valued at
$517.5k
|
|
| 08/13/2018 |
4
| Driscoll Martin J (President and CEO) has filed a Form 4 on Spring Bank Pharmaceuticals, Inc.|
Txns:
| Bought 4,000 shares
@ $12.02, valued at
$48.1k
|
|
| 03/01/2018 |
4
| Driscoll Martin J (President and CEO) has filed a Form 4 on Spring Bank Pharmaceuticals, Inc.|
Txns:
| Bought 1,000 shares
@ $12.83, valued at
$12.8k
|
|
| 01/17/2018 |
4
| Driscoll Martin J (President and CEO) has filed a Form 4 on Spring Bank Pharmaceuticals, Inc.|
Txns:
| Granted 80,000 options to buy
@ $12.1, valued at
$968k
|
|
| 09/14/2017 |
4
| Driscoll Martin J (President and CEO) has filed a Form 4 on Spring Bank Pharmaceuticals, Inc.|
Txns:
| Bought 1,000 shares
@ $14.84, valued at
$14.8k
|
|
| 08/03/2017 |
4
| Driscoll Martin J (President and CEO) has filed a Form 4 on Spring Bank Pharmaceuticals, Inc.|
Txns:
| Bought 1,000 shares
@ $12.28, valued at
$12.3k
Bought 1,000 shares
@ $12.43, valued at
$12.4k
|
|
| 04/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/07/2017 |
4
| Driscoll Martin J (President and CEO) has filed a Form 4 on Spring Bank Pharmaceuticals, Inc. |
| 02/10/2017 |
4
| Driscoll Martin J (President and CEO) has filed a Form 4 on Spring Bank Pharmaceuticals, Inc. |
| 12/16/2016 |
4
| Driscoll Martin J (President and CEO) has filed a Form 4 on Spring Bank Pharmaceuticals, Inc. |
| 12/05/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/01/2016 |
4
| Driscoll Martin J (President and CEO) has filed a Form 4 on Spring Bank Pharmaceuticals, Inc. |
| 11/23/2016 |
4
| Driscoll Martin J (President and CEO) has filed a Form 4 on Spring Bank Pharmaceuticals, Inc. |
| 11/10/2016 |
4
| Driscoll Martin J (President and CEO) has filed a Form 4 on Spring Bank Pharmaceuticals, Inc. |
| 09/02/2016 |
4
| Driscoll Martin J (President and CEO) has filed a Form 4 on Spring Bank Pharmaceuticals, Inc. |
| 08/31/2016 |
4
| Driscoll Martin J (President and CEO) has filed a Form 4 on Spring Bank Pharmaceuticals, Inc. |
| 08/22/2016 |
4
| Driscoll Martin J (President and CEO) has filed a Form 4 on Spring Bank Pharmaceuticals, Inc. |
| 08/16/2016 |
4
| Driscoll Martin J (President and CEO) has filed a Form 4 on Spring Bank Pharmaceuticals, Inc. |
| 08/09/2016 |
4
| Driscoll Martin J (President and CEO) has filed a Form 4 on Spring Bank Pharmaceuticals, Inc. |
| 08/05/2016 |
4
| Driscoll Martin J (President and CEO) has filed a Form 4 on Spring Bank Pharmaceuticals, Inc. |
| 05/20/2016 |
4
| Driscoll Martin J (President and CEO) has filed a Form 4 on Spring Bank Pharmaceuticals, Inc.|
Txns:
| Granted 20,000 options to buy
@ $10.97, valued at
$219.4k
|
|
| 05/12/2016 |
4
| Driscoll Martin J (President and CEO) has filed a Form 4 on Spring Bank Pharmaceuticals, Inc.|
Txns:
| Bought 12,500 shares
@ $12, valued at
$150k
|
|
| 05/05/2016 |
3
| Driscoll Martin J (President and CEO) has filed a Form 3 on Spring Bank Pharmaceuticals, Inc. |
| 08/06/2015 |
4
| Driscoll Martin J (Director) has filed a Form 4 on MetaStat, Inc.|
Txns:
| Bought 5,000 shares
@ $0.28, valued at
$1.4k
Bought 4,100 shares
@ $0.27, valued at
$1.1k
|
|
| 06/26/2015 |
4
| Driscoll Martin J (Director) has filed a Form 4 on MetaStat, Inc.|
Txns:
| Bought 10,000 shares
@ $0.3535, valued at
$3.5k
|
|
| 06/17/2015 |
4/A
| Driscoll Martin J (Director) has filed a Form 4 on MetaStat, Inc.|
Txns:
| Granted 300,000 options
@ $0.55, valued at
$165k
|
|
| 05/20/2015 |
4
| Driscoll Martin J (Director) has filed a Form 4 on MetaStat, Inc.|
Txns:
| Granted 300,000 options
@ $0.39, valued at
$117k
|
|
| 07/02/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|
|